Following the recent expansion of Amazon Omics, as covered in our previous article “Ready, set, analyze: Amazon Omics unveils new Ready2Run workflows”, we wanted to explore the role of third-party providers in shaping the landscape of genomic analysis and bioinformatics. NVIDIA is one of these providers. The GPU company has worked to integrate their Parabricks Ready2Run workflows into Amazon Omics, adding new capabilities to the platform.
To get a better sense of NVIDIA’s role and perspective in this domain, we reached out to Jason Fenwick, genomics business development at the company. In the following interview, Fenwick touches on topics ranging from the unique aspects of NVIDIA’s Parabricks Ready2Run workflows to the acceleration of genome analysis over CPU-based tools. He also explores the company’s collaboration with the GATK team at the Broad Institute, and muses on the company’s NVIDIA AI Enterprise offering.
What distingu…